Lacrimal Duct Stent Tube Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Lacrimal Duct Stent Tube market is segmented by Product Type (Monocanalicular Lacrimal Duct Stent Tube, Bicanalicular Lacrimal Duct Stent Tube), End-User, and Geography

Lacrimal Duct Stent Tube Market Snapshot

Lacrimal Duct Stent Tube Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.2 %
Lacrimal Duct Stent Tube Market Top Companies

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Lacrimal Duct Stent Tube market studied is anticipated to grow with a CAGR of nearly 5.2%, during the forecast period.

Certain factors that are driving the market growth include Increasing patient pool for nasolacrimal duct obstruction and Rising demand for treatments with minimal invasions as well as better success rates.

Nasolacrimal duct obstruction (NLDO) or dacryostenosis is the most common disorder of the lacrimal system. According to the 2020 article, titled “Nasolacrimal Duct Obstruction”, approximately 6% to 20% of newborns patients present with some symptoms. There is a high rate of spontaneous resolution of congenital nasolacrimal duct obstruction with approximately 70% of affected children being free of the symptoms by 3 months of age, and over 90% recovering by their first birthday. However, infants at increased risk for this condition include those with trisomy 21, ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome, branchiooculofacial syndrome, CHARGE (coloboma, heart anomaly, choanal atresia, and retardation, genital and ear anomalies) syndrome, and Goldenhar syndrome. Hence, due to the rising prevalence of such health conditions is expected to drive the market growth over the forecast period.

Scope of the Report

Lacrimal stents are small diameter tubes placed within the nasolacrimal system to maintain patency. In most of the cases, the tubes are typically composed of silicone, or another similar semi-rigid yet flexible material with an open central lumen. Intubation of the nasolacrimal system is generally done temporarily, with stents remaining in place for several months. In rare instances, however, intubation may be long term. Nasolacrimal tubes are used majorly in cases of obstruction or laceration of one or more parts of the tear drainage system.

By Product Type
Monocanalicular Lacrimal Duct Stent Tube
Bicanalicular Lacrimal Duct Stent Tube
By End-User
Ophthalmic Clinics
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Bicanalicular Lacrimal Duct Stent Tube Holds Significant Share in the Global Lacrimal Duct Stent Tube Market

Bicanalicular lacrimal intubation is a successful treatment for children with nasolacrimal duct obstruction, and the younger the age of the children the higher the success rate. Bicanalicular lacrimal tubes have two probes with an intervening stent. One probe is passed through the upper punctum and the other through the lower punctum. The probes are removed, and the free ends of the silicone tube are tied in the nose and sometimes secured with a suture. The longer the duration of the tube retention the better the results, with best results between 3 and 12 months.

Over the past several years, lacrimal intubation has become a very common surgical procedure for congenital nasolacrimal duct obstruction that does not respond to conservative medical treatment or with failed probing. A few other health conditions are also associated with lacrimal duct obstruction which need to be addressed. For instance, Dacryocystitis is an infection or inflammation of the nasolacrimal sac, usually accompanied by blockage of the nasolacrimal duct. The high prevalence of such health conditions are expected to propel the market growth across the globe.

Lacrimal Duct Stent Tube Market Trends

North America Dominates the Global Lacrimal Duct Stent Tube Market

North America is expected to dominate the overall market, throughout the forecast period. In the North American region, the United States holds the largest market share, and this is due to better regulations of surgical devices and growing awareness among the population to approach for such procedures in case of lacrimal duct obstruction and other associated problems. The companies also have well-established direct channel collaboration with hospitals and clinics to serve the studied market.

Lacrimal Duct Stent Tube Market Growth Rate By Region

Competitive Landscape

The global Lacrimal Duct Stent Tube market is competitive and consists of very few major players. Companies like Aurolab, Bess Medizintechnik GmbH, FCI Ophthalmics, Gunther Weiss Scientific Glass, Kaneka Pharma America LLC, among others, hold the substantial market share in the market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Patient Pool for Nasolacrimal Duct Obstruction

      2. 4.2.2 Rising Demand for Treatments with Minimal Invasions as well as Better Success Rates

    3. 4.3 Market Restraints

      1. 4.3.1 Complications Associated with Stent Tubes

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Monocanalicular Lacrimal Duct Stent Tube

      2. 5.1.2 Bicanalicular Lacrimal Duct Stent Tube

    2. 5.2 By End-User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ophthalmic Clinics

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Aurolab

      2. 6.1.2 Bess Medizintechnik GmbH

      3. 6.1.3 FCI Ophthalmics

      4. 6.1.4 Gunther Weiss Scientific Glass

      5. 6.1.5 Kaneka Pharma America LLC

      6. 6.1.6 Becton, Dickinson and Company

      7. 6.1.7 Beaver-Visitec International, Inc

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Lacrimal Duct Stent Tube Market market is studied from 2018 - 2026.

The Lacrimal Duct Stent Tube Market is growing at a CAGR of 5.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

FCI Ophthalmics , Kaneka Pharma America LLC , Aurolab , Bess Medizintechnik GmbH , Gunther Weiss Scientific are the major companies operating in Lacrimal Duct Stent Tube Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!